JungERachitskayaAYonekawaYMurrayTG. Peer-review essentials: reviewing manuscripts for theJournal of Vitreoretinal Diseases. J Vitreoretin Dis. 2025;9(4):401-405. doi:10.1177/24741264251331647
2.
StevanovicMKoulisisNChenT, et al. Intraocular inflammation, safety events, and outcomes after intravitreal injection of ranibizumab, aflibercept, brolucizumab, abicipar pegol, and faricimab for nAMD. J Vitreoretin Dis. 2025;9(4):406-415. doi:10.1177/24741264251332515
3.
WengPJMorganRGrewalDSFekratS. Possible association between dopamine antagonists and increased conversion to exudative age-related macular degeneration. J Vitreoretin Dis. 2025;9(4):416-422. doi:10.1177/24741264251330338
4.
WakabayashiTHaraCShirakiA, et al. Intravitreal aflibercept with vs without pneumatic displacement for submacular hemorrhage associated with polypoidal choroidal vasculopathy. J Vitreoretin Dis. 2025;9(4):423-431. doi:10.1177/24741264251335629
5.
DrummondSCBicknellBTFeistJECrossonJNFeistRM. Long-term cost analysis of initial panretinal photocoagulation for proliferative diabetic retinopathy performed in the operating room vs the clinic. J Vitreoretin Dis. 2025;9(4):432-437. doi:10.1177/24741264251346822
6.
BomdicaPRShepherdEAGuptaRChaturvediV. Timing of epiretinal membrane surgery after uncomplicated retinal detachment repair. J Vitreoretin Dis. 2025;9(4):438-444. doi:10.1177/24741264251337107
7.
AdelbergDAParsonsMT. Wavefront aberrometry in pseudophakic patients before and after vitrectomy for bothersome floaters. J Vitreoretin Dis. 2025;9(4):445-450. doi:10.1177/24741264251333200
8.
UyHSArtiagaJCMLimKBMChanPSFamadicoJT. Clinical performance and outcomes of a 20 000 cuts-per-minute, beveled-tip vitrectomy probe. J Vitreoretin Dis. 2025;9(4):451-458. doi:10.1177/24741264251338871
9.
YuanMKozekLKHoyekS, et al. Clinical characteristics, outcomes, and complications associated with delayed diagnosis of intraocular foreign body. J Vitreoretin Dis. 2025;9(4):459-466. doi:10.1177/24741264251339090
10.
LeeRDuJWanELKimGAliMHLaiMM. Patient satisfaction in ophthalmology: the impact of remote scribes. J Vitreoretin Dis. 2025;9(4):467-473. doi:10.1177/24741264251340104
11.
GonzálezNCVillegasVMGoldASLatiffAMurrayTG. Early treatment in patients with small and medium-small class 2 gene expression profiling uveal melanoma to reduce mortality. J Vitreoretin Dis. 2025;9(4):474-478. doi:10.1177/24741264251337101
EngerADossettJClavellC, et al. Delayed-onset endophthalmitis after intravitreal dexamethasone implantation. J Vitreoretin Dis. 2025;9(4):489-493. doi:10.1177/24741264251346825
14.
HillCArhontoulisDCBuiHDeVaroSMTangPH. Bilateral sterile granulomatous uveitis caused by intravitreal injections of faricimab. J Vitreoretin Dis. 2025;9(4):494-497. doi:10.1177/24741264251330339
15.
GoldburgSRLiAS. Multiple successive branch retinal artery occlusions in a patient with antiphospholipid syndrome despite anticoagulation. J Vitreoretin Dis. 2025;9(4):498-502. doi:10.1177/24741264251331638
16.
ApelWLiY. Bullous central serous chorioretinopathy associated with JAK inhibitor use. J Vitreoretin Dis. 2025;9(4):503-506. doi:10.1177/24741264251337104
17.
KokameGTNakahiraSYamaneKChenJLuoETomES. Resolution of myopic macular retinoschisis and macular hole with topical medical therapy. J Vitreoretin Dis. 2025;9(4):507-510. doi:10.1177/24741264251340107
18.
LatasiewiczMAdamsMHelmyY. Bandage contact lens as an alternative to a temporary keratoprosthesis for vitrectomy with concurrent corneal opacity. J Vitreoretin Dis. 2025;9(4):511-514. doi:10.1177/24741264251340110
19.
ArnoldNMishraASeamoneM. Cancer-associated retinopathy presenting as panuveitis secondary to minimally invasive follicular thyroid carcinoma. J Vitreoretin Dis. 2025;9(4):515-518. doi:10.1177/24741264251337108
20.
MaywoodMJFaiaLJBegajT. Long-term follow-up of cytomegalovirus retinitis in an immunocompetent patient. J Vitreoretin Dis. 2025;9(4):519-522. doi:10.1177/24741264251338042
